Effect of surfactant on the preparation and characterization of gemcitabine-loaded particles
Gemcitabine is used in the treatment of several solid tumors as one of anticancer nucleoside analogues and is necessary to administer high doses to achieve the desired therapeutic response. However, this treatment may be related to severe side effects. For improvement of the encapsulation efficiency of gemcitabine for gemcitabine-loaded nanoparticle composed of biodegradable polymer and reducing the side effects due to the high concentration of gemcitabine, we formulated gemcitabine-loaded PLGA particles using chitosan and different type of surfactant. The gemcitabine-loaded particles were prepared using a double emulsion solvent evaporation technique. The effects of surfactants to modify the size of gemcitabine-loaded particles were different. The mean diameters of gemcitabine-loaded particles ranged from 400.8 nm to 1712.7 nm. The surface charge of gemcitabine particles was − 5.62 mV to 1.46 mV. The encapsulation efficiency of gemcitabine-loaded particles was found to be 29.56–34.38%. Interestingly, the addition of surfactant could be improved an encapsulation efficiency of gemcitabine.
KeywordsGemcitabine Polymeric nanoparticles Surfactan Encapsulation efficiency Cytotoxicity
This article does not contain any studies with human and animal subjects performed by any of the authors. All authors (J.H. Lim, Y.G. Na, H.K. Lee, K.H. Bang, S.J. Kim, H.J. Lee, M. Wang, Y.C. Pyo, H.W. Huh, C.W. Cho) declare that they have no conflict of interest. This work was supported by the research fund of Chungnam National University.
- Horton ND (2004) Toxicity of single-dose oral gemcitabine in mice. Cancer Res 4:27–31Google Scholar
- Jang JY, Kwon BS, Lee HE, Kim DH, Kang HK, Kang JS, Lee SK, Choi GJ (2007) Preparation of biodegradable PLGA nanospheres employing a fast solvent evaporation method. J Ind Eng Chem 13:1043–1046Google Scholar
- Myhren F, Borretzen B, Dalen A, Sandvold ML (2002) Gemcitabine derivatives. US Patent US2,002,042,391Google Scholar
- Storniolo AM, Allerheiligen SRB, Pearce HL (1997) Preclinical, pharmacologic, and phase I studies of gemcitabine. Semin Oncol 24:S7-2–S7-7Google Scholar
- Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, Douziech-Eyrolles L, Soucé M, Dubois P, Chourpa I (2007) Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm 66:488–492CrossRefPubMedGoogle Scholar
- Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J (2012) Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Eur J Pharm Biopharm 45:632–638Google Scholar